BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1161319)

  • 1. Attempt with immunotherapy to control metastatic skin nodules from breast cancer by B.C.G.
    Garas J; Besbeas S; Papamatheakis J; Gropas G; Maragoudakis S; Katsenis A; Kiparissiadis P; Konstadakos P; Georgaka A
    Panminerva Med; 1975; 17(5-6):193-5. PubMed ID: 1161319
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)].
    Sakurai T; Okada K; Yokoi H; Maebeya S; Juri M; Takimoto M; Nishimura O; Okada N
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1838-42. PubMed ID: 6476845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive therapeutic response to BCG or to its soluble fraction F70 in some patients with carcinoma of the skin, of the breast or of the larynx.
    Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):43-8. PubMed ID: 944214
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant immunotherapy.
    Goodnight JE; Morton DL
    Int Adv Surg Oncol; 1978; 1():53-83. PubMed ID: 399764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective BCG stimulation in patients treated with melphalan after mastectomy.
    Adler A; Stein JA; Ben-Efraim S
    Isr J Med Sci; 1977 Aug; 13(8):837-43. PubMed ID: 330456
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy of patients with cancer.
    Smith GV; Morse PA; Deraps GD; Raju S; Hardy JD
    Surgery; 1973 Jul; 74(1):59-68. PubMed ID: 4715883
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction: Immunotherapy of cancer in man, a reality.
    Klein E
    Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis].
    Wolf M; Menzel W
    Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer.
    Hortobagyi GN; Buzdar AU; Blumenschein GR; Yap HY; Hersh EM
    Dev Biol Stand; 1986; 58 ( Pt A)():357-63. PubMed ID: 3596041
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant immunotherapy after surgery and radiotherapy for breast carcinoma.
    Papavasiliou C; Pappas J; Pavlatou M; Keramopoulos A; Giannakoulis N; Koumantakis E; Nicolaïdis C
    Strahlentherapie; 1982 Apr; 158(4):206-9. PubMed ID: 7101333
    [No Abstract]   [Full Text] [Related]  

  • 11. Metastatic sarcoma. Combined surgical and immunotherapeutic approach. Neuraminidase treated tumor cells as tumor vaccine.
    Gunnarsson A; McKhann CF; Simmons RL; Grage TB
    Minn Med; 1974 Jul; 57(7):558-61. PubMed ID: 4845897
    [No Abstract]   [Full Text] [Related]  

  • 12. Divergent effect of adjuvant chemo-immunotherapy on recurrence rates in node-negative and node-positive breast cancer patients.
    Jungi WF; Senn HJ; Amgwerd R; Hochuli E
    Eur J Cancer (1965); 1980; Suppl 1():169-72. PubMed ID: 7032928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Present state of the multidisciplinary treatment of locoregionally advanced breast cancer].
    Izuo M; Iino Y
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1153-9. PubMed ID: 3840541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
    Grigorovich NA; Risina DIa; Nodel'son SE
    Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCG immunotherapy in localized forms of breast carcinoma].
    Munzarová M; Kovarík J; Hlávková J; Pacovský Z
    Cas Lek Cesk; 1986 Oct; 125(43):1321-4. PubMed ID: 3508734
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with nonspecific immunotherapy of tumour processes by BCG vaccine (author's transl)].
    Andrysek O; Mostecký H; Dienstbier Z
    Cas Lek Cesk; 1974 Sep; 113(38):1170-2. PubMed ID: 4607393
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy in breast cancer.
    Pederzini A
    Panminerva Med; 1973; 15(11-12):435-6. PubMed ID: 4806258
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer management: recent advances and recommendations.
    Levine RM; Lippman ME
    Adv Intern Med; 1984; 29():215-44. PubMed ID: 6369926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.